Two arrested over counterfeit version of Sun Pharma drugs seized in Hyderabad

Published On 2025-06-27 11:02 GMT   |   Update On 2025-06-27 11:02 GMT

arrested

Hyderabad: The Drugs Control Administration (DCA), Telangana, has arrested two individuals involved in dealing with spurious ‘Rosuvas F 20’ and ‘Rosuvas F 10’ tablets, falsely claimed to be manufactured by Sun Pharmaceutical Industries Ltd. 

The accused were arrested by the Drugs Control Administration officers and produced before the Hon’ble II Additional Chief Judicial Magistrate (ACJM) Court, Nampally, Hyderabad. The court ordered a 14-day judicial remand for the two accused, until 9th July, 2025, and they were subsequently sent to Chanchalguda Jail.

The arrested individuals have been identified as Praveen Kumar Kanodia, of Ganga Pharma Distributors, and Mithinti Srinivas, of Sri Nandini Pharma, both operating out of the Koti area in Hyderabad.

The incident was reported by Medical Dialogues, which noted that the arrests followed raids by the DCA on two dealers — Ganga Pharma Distributors and Sri Nandini Pharma.

The raids led to the detection of Spurious Drugs (Counterfeit Versions) Rosuvas F 20 and Rosuvas F 10 which were seized by the DCA officers on 19th June, 2025.

Rosuvas F 20 and Rosuvas F 10 Tablets are used to lower cholesterol and triglyceride levels in the blood and help prevent heart-related problems.
A comparison statement for the suspected batches was obtained from the original manufacturer, Sun Pharmaceutical Industries Ltd., against the corresponding original batches. The manufacturer confirmed that the batches of ‘Rosuvas F 20’ and ‘Rosuvas F 10’ Tablets (Rosuvastatin and Fenofibrate Tablets) detected by the Drugs Control Administration were indeed “Counterfeit Drugs”.
Spurious drugs pose a significant threat to public health, endangering patients' well-being. These drugs not only fail to treat the intended diseases but can also lead to severe health complications over time. Further investigation is in progress to trace the source of the counterfeit drugs and to identify others involved in this illegal activity.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News